Drug Trial Radar · NCT04891237
Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
Last checked: Nov 20, 2026Latest source record: May 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
180
Planned (sponsor's estimate)
Start
Jun 14, 2021
Primary completion
Jan 2026
Study completion Jan 2027
Sponsor
- Lead sponsor
- Inmunotek S.L.Industry
- Sponsor type
- Industry
- First posted
- May 18, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 12 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial of efficacy and safety with subcutaneous immunotherapy in patients with mild to moderate rhinitis / rhinoconjunctivitis with or without mild to moderate asthma sensitized to grasses and olive
Conditions
- Rhinitis, Allergic
- Rhinoconjunctivitis
- Asthma, Allergic
Interventions
10,000 MG01 + 10,000 T517Biological
Purified and polymerized with glutaraldehyde allergen extract, from a mixture of grasses (Phleum pratense, Holcus lanatus, Poa pratensis, Festuca pratensis, Lolium perenne and Dactylis glomerata) and Olea (Olea europaea), adsorbed on aluminum hydroxide. The other ingredients are: sodium chloride (0.9%), phenol (0.4%) and water for injections
30,000 MG01 + 10,000 T517Biological
Purified and polymerized with glutaraldehyde allergen extract, from a mixture of grasses (Phleum pratense, Holcus lanatus, Poa pratensis, Festuca pratensis, Lolium perenne and Dactylis glomerata) and Olea (Olea europaea), adsorbed on aluminum hydroxide. The other ingredients are: sodium chloride (0.9%), phenol (0.4%) and water for injections
PlaceboOther
The same solution and presentation as the active treatment, but without active ingredients
Primary outcomes
What the sponsor says the trial is designed to measure.
- CSMS: Combined Symptoms and Medication ScoreTime frame: 12 months
Locations
32 sites in 1 country. Site status is shown where the registry gives one.
Private Practice
Albacete, Spain · Withdrawn
Hospital Ntra. Sra. de Sonsoles
Ávila, Spain · Recruiting
Clinica Dermatologica Y Alergia
Badajoz, Spain · Recruiting
Hospital Quironsalud Clideba
Badajoz, Spain · Recruiting
Hospital Universitario Dexeus
Barcelona, Spain · Recruiting
Clínica privada Barcelona
Barcelona, Spain · Withdrawn
Hospital General Universitario Ciudad Real
Ciudad Real, Spain · Recruiting
Hospital Quironsalud Córdoba
Córdoba, Spain · Recruiting
Hospital Universitario Clínico San Cecilio
Granada, Spain · Active not recruiting
Hospital Universitario de Jaén
Jaén, Spain · Recruiting
Hospital Universitari Santa María
Lleida, Spain · Recruiting
Private practice
Madrid, Spain · Withdrawn
Hospital Universitario Cruz Roja
Madrid, Spain · Recruiting
Clínica de Asma y Alergia en Madrid | CLÍNICA OJEDA
Madrid, Spain · Recruiting
Clínica Subiza
Madrid, Spain · Recruiting
Hospital Carlos Iii
Madrid, Spain · Completed
Hospital Universitario Rey Juan Carlos
Madrid, Spain · Withdrawn
Hospital Quirónsalud Málaga
Málaga, Spain · Recruiting
Private Practice
Málaga, Spain · Recruiting
Private Practice
Murcia, Spain · Recruiting
Private Practice
Palencia, Spain · Completed
Hospital Universitario Infanta Cristina
Parla, Spain · Recruiting
Clínica privada Sevilla
Seville, Spain · Withdrawn
Hospital Virgen Del Rocío
Seville, Spain · Recruiting
Hospital Viamed Santa Ángela de La Cruz
Seville, Spain · Recruiting
Private Practice
Toledo, Spain · Withdrawn
Hospital Recoletas Felipe Ii
Valladolid, Spain · Recruiting
Cedt de Tarancón
Tarancón, Cuenca, Spain · Recruiting
Hospital Universitario Principe de Asturias
Alcalá de Henares, Madrid, Spain · Completed
Centro Médico Iza
Tres Cantos, Madrid, Spain · Recruiting
Hospital Infanta Elena
Valdemoro, Madrid, Spain · Recruiting
Hospital Clínico Universitario Virgen de Arrixaca
El Palmar, Murcia, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.